On metabolic deteriorations in pentylenetetrazol (PTZ) kindled rats revealed with glucose tolerance test and liver histology

Pastukhov, O. O.; Pervak, M. P.; Smirnov, I. V.; Bukreeva, N. I.; Litvinenko, M. V.; Godlevsky, L. S.

dc.contributor.author	Pastukhov, O. O.	en
dc.contributor.author	Pervak, M. P.	en
dc.contributor.author	Smirnov, I. V.	en
dc.contributor.author	Bukreeva, N. I.	en
dc.contributor.author	Litvinenko, M. V.	en
dc.contributor.author	Godlevsky, L. S.	en
dc.date.accessioned	2024-09-25T06:26:13Z
dc.date.available	2024-09-25T06:26:13Z
dc.date.issued	2024
dc.identifier.citation	On metabolic deteriorations in pentylenetetrazol (PTZ) kindled rats revealed with glucose tolerance test and liver histology / O. O. Pastukhov, M. P. Pervak, I. V. Smirnov et al. // Acta Neurobiol Exp. 2024. Vol. 84. P. 146.	en
dc.identifier.uri	https://repo.odmu.edu.ua:443/xmlui/handle/123456789/15958
dc.description.abstract	Manifestations of metabolic syndrome (MS) man‑ ifestations in chronic epilepsy models were in the scope of the investigation. Kindling was induced by daily injections of PTZ at a dose of 35 mg/kg i.p. for three weeks. Those animals with fully developed gen‑ eralized seizures were used for investigations. Glucose and insulin levels were not different from control rats, while PTZ‑kindled rats demonstrated decreased tol‑ erance to glucose tests.	en
dc.language.iso	en	en
dc.subject	metabolic deteriorations	en
dc.subject	pentylenetetrazol	en
dc.subject	glucose tolerance test	en
dc.subject	liver histology	en
dc.title	On metabolic deteriorations in pentylenetetrazol (PTZ) kindled rats revealed with glucose tolerance test and liver histology	en
dc.type	Article	en